These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 4340493)

  • 1. [Japanese encephalitis vaccine].
    Otani A
    Hokenfu Zasshi; 1972 Apr; 28(4):62-3. PubMed ID: 4340493
    [No Abstract]   [Full Text] [Related]  

  • 2. IC51 Japanese encephalitis vaccine.
    Kollaritsch H; Paulke-Korinek M; Dubischar-Kastner K
    Expert Opin Biol Ther; 2009 Jul; 9(7):921-31. PubMed ID: 19527110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A chimeric live attenuated vaccine against Japanese encephalitis.
    Jones T
    Expert Rev Vaccines; 2004 Jun; 3(3):243-8. PubMed ID: 15176941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Japanese encephalitis: development of new candidate vaccines.
    Bharati K; Vrati S
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):313-24. PubMed ID: 16597211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Production of purified Japanese encephalitis vaccine from Vero cells with roller bottles].
    Ding Z; Shi H; Pang C
    Zhonghua Yi Xue Za Zhi; 1998 Apr; 78(4):261-2. PubMed ID: 10923479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Japanese encephalitis vaccine for travelers: exploring the limits of risk.
    Shlim DR; Solomon T
    Clin Infect Dis; 2002 Jul; 35(2):183-8. PubMed ID: 12087525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Japanese encephalitis: is there a need for a novel vaccine?
    Wilder-Smith A; Freedman DO
    Expert Rev Vaccines; 2009 Aug; 8(8):969-72. PubMed ID: 19627179
    [No Abstract]   [Full Text] [Related]  

  • 9. A new inactivated Japanese encephalitis vaccine for adult travelers.
    Toovey S
    Travel Med Infect Dis; 2009 Sep; 7(5):301-4. PubMed ID: 19747666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of a single dose of a vaccine (SA14-14-2) against Japanese encephalitis].
    Diagana M; Ngoungou EB; Preux PM
    Med Trop (Mars); 2006 Apr; 66(2):205. PubMed ID: 16775949
    [No Abstract]   [Full Text] [Related]  

  • 11. A new Japanese encephalitis vaccine (Ixiaro).
    Med Lett Drugs Ther; 2009 Aug; 51(1319):66-7. PubMed ID: 19696707
    [No Abstract]   [Full Text] [Related]  

  • 12. Japanese encephalitis vaccines: moving away from the mouse brain.
    Zanin MP; Webster DE; Martin JL; Wesselingh SL
    Expert Rev Vaccines; 2003 Jun; 2(3):407-16. PubMed ID: 12903806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Japanese encephalitis vaccine.
    Dubey AP;
    Indian Pediatr; 2000 Oct; 37(10):1083-4. PubMed ID: 11042706
    [No Abstract]   [Full Text] [Related]  

  • 14. IC51: a new investigational Japanese encephalitis vaccine. Dr Christoph Klade speaks to Duc Le, editor.
    Klade CS
    Expert Rev Vaccines; 2008 Oct; 7(8):1139-40. PubMed ID: 18844587
    [No Abstract]   [Full Text] [Related]  

  • 15. Potency testing of inactivated tissue culture vaccine against Japanese encephalitis using antigen capture ELISA.
    Joshi AM; Walimbe AM; Banerjee K
    Acta Virol; 1997 Jun; 41(3):157-9. PubMed ID: 9385404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yellow fever and Japanese encephalitis vaccines: indications and complications.
    Marfin AA; Eidex RS; Kozarsky PE; Cetron MS
    Infect Dis Clin North Am; 2005 Mar; 19(1):151-68, ix. PubMed ID: 15701552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A special note on Japanese encephalitis vaccine.
    Lamabadusuriya SP
    Ceylon Med J; 1993 Sep; 38(3):103-4. PubMed ID: 7828224
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
    Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
    J Gene Med; 2009 Feb; 11(2):150-9. PubMed ID: 19040206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single dose of inactivated Japanese encephalitis vaccine with poly(gamma-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virus.
    Okamoto S; Yoshii H; Ishikawa T; Akagi T; Akashi M; Takahashi M; Yamanishi K; Mori Y
    Vaccine; 2008 Jan; 26(5):589-94. PubMed ID: 18180081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.